Reference:
1. Phabphal K, Geater A, Leelawattana R, Sathirapunya P, Sattawatcharawanich S, Limapichat K. Prevalence and risk factors of low bone mineral density and 25-hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug. Bone 2009; 45:232–7.
2. Mintzer S, Mattson RT.Should enzyme-inducing antiepileptic drugs be considered first-line agents?. Epilepsia 2009; 50(Suppl. 8): 42–50.
3. Anderson GD. Pharmacogenetics and enzyme induction/
inhibition properties of antiepileptic drugs. NEUROLOGY 2004;63(Suppl
4):S3–S8.
Keywords:
-